5. Clinical Practice of Hepatitis: Myocardial Diseases, Nephritis, and Vasculitis Associated with Hepatitis Virus

Internal Medicine

Volumn 40, Issue 2, 2001, Pages 182-184

  Matsumori, Akira ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Cardiomyopathy; Hepatitis B virus; Hepatitis C virus; Myocarditis

Indexed keywords

ANTIVIRUS AGENT; BIOLOGICAL MARKER; INTERFERON; VIRUS RNA;

ADULT; CARDIOMYOPATHY; CHEMICALLY INDUCED DISORDER; CHILD; CONGESTIVE CARDIOMYOPATHY; FEMALE; GLOMERULONEPHRITIS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISOLATION AND PURIFICATION; JAPAN; MALE; MULTICENTER STUDY; PATHOGENICITY; POLYARTERITIS NODOSA; PREVALENCE; REVIEW; VIROLOGY;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CARDIOMYOPATHIES; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CHILD; FEMALE; GLOMERULONEPHRITIS; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; INTERFERONS; JAPAN; MALE; MULTICENTER STUDIES; POLYARTERITIS NODOSA; PREVALENCE; RNA, VIRAL;

EID: 0035261597     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.40.182     Document Type: Article

References (13)

1. Baboonian C, Treasure T. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78: 539-543, 1997.
2. Matsumori A, Matoba Y, Sasayama S. Dilated cardiomyopathy associated with hepatitis C virus infection. Circulation 92, 2519-2525, 1995.
3. Matsumori A, Matoba Y, Nishio R, Shioi T, Ono K, Sasayama S. Detection of hepatitis C virus RNA from the heart of patients with hypertrophic cardiomyopathy Biochem Biophys Res Commun 222: 678-682, 1996.
4. Matsumori A. Molecular and immune mechanisms in the pathogenesis of cardiomyopathy-role of viruses, cytokines, and nitric oxide. Jpn Circ J 61: 275-291, 1997.
5. Matsumori A, Ohashi N. Hasegawa K, et al. Hepatitis C virus infection and heart diseases. A multicenter study in Japan. Jpn Circ J 62: 389-391, 1998.
6. Matsumori A, Ohashi N, Sasayama S. Hepatitis C virus infection and hypertrophie cardiomyopathy. Ann Int Med 129: 749-750, 1998 (letter).
7. Matsumori A, Ohashi N, Nishio R, et al. Apical hypertrophic cardiomyopathy and hepatitis C virus infection. Jpn Circ J 63: 433-438, 1999.
8. Okabe M, Fukuda K, Arakawa K, Kikuchi M. Chronic variant of myocarditis associated with hepatitis C virus infection. Circulation 96: 22-24, 1997.
9. Sato Y, Takatsu Y, Yamada T, et al. Interferon treatment for dilated cardiomyopathy and striated myopathy associated with hepatitis C virus infection based on serial measurements of serum concentration of cardiac troponin T. Jpn Circ J 64: 321-324, 2000.
10. Yamabe H, Johnson RJ, Gretch DR, et al. Hepatitis C virus infection and membranoproliferative glomerulonephritis in Japan. J Am Soc Nephrol 6: 220-223, 1995.
11. Garcia-Valdescasas J, Bernai C, Garcia F, et al. Epidemiology of hepatitis C virus infection in patients with renal disease. J Am Soc Nephrol 5: 186-192, 1994.
12. Watanabe H, Ono T, Muso E, Matsumori A, Sasayama S. Hepatitis C virus manifesting as tubulointerstitial nephritis, cardiomyopathy, and hepatitis. Am J Med 109: 176-177, 2000 (letter).
13. Willson RA. Extrahepatic manifestations of chronic viral hepatitis. Am J Gastroenterol 92: 3-17, 1997.